The Wolverine Blend:
· BPC-157: A 15-amino acid gastric peptide that modulates the NO system, promotes angiogenesis via VEGF upregulation, activates FAK-paxillin signaling, and demonstrates cytoprotective activity across gastrointestinal, musculoskeletal, neural, and cardiovascular tissue.
· TB-500: A 43-amino acid peptide that regulates actin polymerization to control cell migration, promotes blood vessel formation through independent vascular pathways, activates satellite cells in muscle tissue, and provides anti-inflammatory signaling.
Uses: The BPC-157 / TB-500 Blend is a dual-peptide research combination widely used in preclinical studies focused on tissue organization, cellular migration, angiogenic signaling, and cytoskeletal dynamics.
Wolverine Blend - BPC-157/ TB-500
*YOU WILL BE ABLE TO UPDATE QUANITY ONCE YOU ADD PRODUCT TO CART
Save up to 20% on Bulk Orders
| Range (Qty) | Price |
|---|---|
| 3 - 4 | $76.63 |
| 5 - 6 | $75.05 |
| 7 - 9 | $73.47 |
| 10 - 19 | $71.10 |
| 20 + | $63.20 |
Disclaimer:
All products sold by Blue Door Longevity are for laboratory research use only. They are not intended for human consumption, medical use, or therapeutic purposes. These products have not been evaluated by the FDA and are not designed to diagnose, treat, cure, orprevent any disease.
Free Shipping for
orders over $500
Free Shipping on orders over $500
Related products
© Blue Door Longevity. All rights reserved.
All products offered on this website are provided exclusively for laboratory research and development purposes. They are not intended for human consumption under any circumstances. Statements made on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Our products and related information are not intended to diagnose, treat, cure, or prevent any disease.
Blue Door Longevity is a research chemical supplier. We are not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B of the same Act.